The Anticancer Mechanism of the Ribonucleotide Reductase Inhibiting Drug COH29 Involves Suppression of DNA Repair

ABSTRACT: Mechanism of Action Study for COH29 Compare COH29 treatment in DNA-repair deficient cell line with truncated BRCA1 (HCC1937) versus phenotypically normal cell line with exogenous WT BRCA1 expression (HCC1937+BRCA1)

ORGANISM(S): Homo sapiens

SUBMITTER: Charles Warden 

PROVIDER: E-GEOD-55004 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress